الإحصائيات الأساسية
| LEI | 549300EFZIFW7F7I0Q28 |
| CIK | 1220754 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ModivCare Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 20, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 22, 2025 |
Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing Exhibit 99.1 Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing Denver, CO – August 22, 2025 – Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, announced that, on August 21, 2025, the Company was notified by the Lis |
|
| August 21, 2025 |
Exhibit 99.2 |
|
| August 21, 2025 |
Exhibit 99.1 Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital Supermajority support of secured lenders outlined in Restructuring Support Agreement and via commitment for $100 million in a new investment to support operations and the future growth of the Company Operations and service lines continue uninterrupted, with no expected |
|
| August 21, 2025 |
The remainder of this page is intentionally blank. Signature page follows. Exhibit 10.3 August 14, 2025 [ ] By electronic email Re: Retention Bonus Dear [ ]: We consider your continued service and dedication to Modivcare Solutions LLC (collectively with its subsidiaries and affiliates and any successors thereto, “Modivcare”) essential to our business. To encourage you to remain employed with Modivcare and to address any concerns about your job security, we are pleased to |
|
| August 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 21, 2025 |
Exhibit 10.4 August 15, 2025 L. Heath Sampson 64 Windsor Way, Greenwood Village, CO 80111 Re: Amended and Restated Employment Terms Dear Heath, This letter sets forth the current terms and conditions of your continued employment in the position of Chief Executive Officer with Modivcare. Effective Date: This letter will be effective as of the date set forth above. In your role, you will continue to |
|
| August 21, 2025 |
Exhibit 10.2 Final Version Priviledged & Confidential SUPERPRIORITY SECURED DEBTOR IN POSSESSION CREDIT AGREEMENT dated as of August [ ], 2025 among MODIVCARE INC. The Lenders Party Hereto, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent Table of Contents Page ARTICLE I Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Classification of Loans and Bo |
|
| August 21, 2025 |
RESTRUCTURING SUPPORT AGREEMENT Exhibit 10.1 Execution Version THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER OR ACCEPTANCE WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ACCEPTANCES OF A CHAPTER 11 PLAN WITHIN THE MEANING OF SECTIONS 1125 AND 1126 OF THE BANKRUPTCY CODE. ANY SUCH OFFER OR SOLICITATION WILL COMPLY WITH ALL APPLICABLE SECURITIES LAWS AND/OR PROVISIONS OF THE BANKRUPTCY CODE. NOTHING CONTAINED IN THIS R |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SEC FILE NUMBER 001-34221 CUSIP NUMBER 6078X104 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2025 ☐Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐Transition Report on Form 11-K ☐Transition R |
|
| July 10, 2025 |
Modivcare Regains Compliance with Nasdaq Continued Listing Standard Modivcare Regains Compliance with Nasdaq Continued Listing Standard Denver, CO – July 10, 2025 – Modivcare Inc. |
|
| July 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 7, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commis |
|
| June 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 17, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commis |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare |
|
| May 8, 2025 |
Modivcare Reports First Quarter 2025 Financial Results Modivcare Reports First Quarter 2025 Financial Results Denver, CO – May 8, 2025 – Modivcare Inc. |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| May 5, 2025 |
Modivcare Announces Executive Leadership Transitions as Part of Strategic Business Model Evolution FOR IMMEDIATE RELEASE Modivcare Announces Executive Leadership Transitions as Part of Strategic Business Model Evolution Denver, CO — May 5, 2025 — Modivcare Inc. |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 1, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Comm |
|
| April 25, 2025 |
Modivcare Announces Changes to Board of Directors Modivcare Announces Changes to Board of Directors Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance April 25, 2025 DENVER-(BUSINESS WIRE)-Modivcare Inc. |
|
| April 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 2, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 13, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Comm |
|
| March 14, 2025 |
Exhibit 4.1 FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of March 14, 2025, among ModivCare Inc., a Delaware corporation (the “Issuer”), the guarantors party hereto (the “Guarantors”) and Ankura Trust Company, LLC, as trustee (in such capacity, the “Trustee”) and notes collateral agent (in such capacity, the “Notes Collateral Agent”). W I T N |
|
| March 11, 2025 |
Exhibit 4.1 FIFTH SUPPLEMENTAL INDENTURE Fifth Supplemental Indenture (this “Supplemental Indenture”), dated as of March 7, 2025, among ModivCare Inc., a Delaware corporation (the “Issuer”), the guarantors party hereto (the “Guarantors”) and Wilmington Saving Fund Society, FSB (as successor to The Bank of New York Mellon Trust Company, N.A.), as trustee (the “Trustee”). W I T N E S S E T H WHEREAS |
|
| March 11, 2025 |
Exhibit 4.2 SECOND LIEN SENIOR SECURED PIK TOGGLE NOTES INDENTURE Dated as of March 7, 2025 Among MODIVCARE INC., as the Issuer, the GUARANTORS party hereto from time to time and ANKURA TRUST COMPANY, LLC as Trustee and Notes Collateral Agent 5.000% / 10.000% SECOND LIEN SENIOR SECURED PIK TOGGLE NOTES DUE 2029 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1 |
|
| March 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 11, 2025 (March 7, 2025) ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or org |
|
| March 6, 2025 |
Letter Agreement, dated December 23, 2024, by and between the registrant and Craig Barbarosh. INDEPENDENT DIRECTOR SERVICE AGREEMENT This INDEPENDENT DIRECTOR SERVICE AGREEMENT (this “Agreement”) is made as of December 23, 2024 (the “Effective Date”) by and between ModivCare Inc. |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. |
|
| March 6, 2025 |
Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors Denver, CO – March 6, 2025 – Modivcare Inc. |
|
| March 6, 2025 |
ModivCare Inc. Insider Trading Policy ex191modvinsidertradingp Proprietary and Confidential Rev. December 2024 1 RESPECT • TRUST • RELIABLE • COMPASSION • SAFETY • TRANSPARENCY Modivcare Policy #2031 Initial Effective Date: 08/17/2021 2031 MODIVCARE INC INSIDER TRADING POLICY Purpose: The purpose of this policy is to provide Teammates, officers, directors, and other individuals associated with our organization a comprehensive framewor |
|
| March 6, 2025 |
orm of Restricted Stock Unit Agreement for awards granted in 2024 and thereafter. Exhibit 10.22 RESTRICTED STOCK UNIT AGREEMENT To: [NAME] You are hereby awarded, effective as of the Date of Grant, restricted stock units (each a “RSU” and collectively the “RSUs”) set forth below, each representing the right to receive shares of common stock, $.001 par value (“Common Stock”), of Modivcare Inc., a Delaware corporation (the “Company”), pursuant to the Company’s 2006 Long‐Term Ince |
|
| March 6, 2025 |
Subsidiaries of the Registrant. Exhibit 21.1 Name of Subsidiary State/Country of Incorporation Unless otherwise noted all subsidiaries listed are, directly or indirectly, wholly owned by ModivCare Inc. ModivCare Solutions, LLC Delaware Circulation, Inc. Delaware Health Trans, Inc. Delaware Provado Technologies, LLC Florida Red Top Transportation, Inc. Florida Ride Plus, LLC Delaware Ingeus Investments Limited United Kingdom Inge |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 6, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| March 6, 2025 |
Exhibit 10.16 MODIVCARE INC. DIRECTOR COMPENSATION SUMMARY As compensation for their service as directors of ModivCare Inc. (the “Company”), each non-employee member of the Board of Directors (the “Board”) who does not have a written letter agreement with the Company providing for an alternative compensatory arrangement receives the following combination of cash and Company equity (prorated for pa |
|
| March 6, 2025 |
Form of Restricted Stock Agreement Exhibit 10.20 RESTRICTED STOCK AGREEMENT – DIRECTORS To: Award Date: You are hereby awarded, effective as of the date hereof, [] shares (the “Shares”) of common stock, $.001 par value (“Common Stock”), of ModivCare Inc., a Delaware corporation (the “Company”), pursuant to the Company’s 2006 Long-Term Incentive Plan, as amended (the “Plan”), subject to certain Restrictions (as defined below) specif |
|
| March 6, 2025 |
Letter Agreement, dated December 23, 2024, by and between the registrant and Neal Goldman. INDEPENDENT DIRECTOR AGREEMENT THIS INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”) is made as of December 23, 2024 (the “Effective Date”), by and between ModivCare Inc. |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by R |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 3, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| February 28, 2025 |
Exhibit 99.1 Modivcare to Report Fourth Quarter and Full Year 2024 Financial Results and Adjourn Special Meeting to Follow Report February 28, 2025 DENVER-(BUSINESS WIRE)-Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced |
|
| February 28, 2025 |
Press release dated February 28, 2025. Exhibit 99.1 Modivcare to Report Fourth Quarter and Full Year 2024 Financial Results and Adjourn Special Meeting to Follow Report February 28, 2025 DENVER-(BUSINESS WIRE)-Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by R |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2025 (February 23, 2025) ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation |
|
| February 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2025 (February 10, 2025) ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation |
|
| February 14, 2025 |
Exhibit 99.1 Modivcare Announces Changes to Board of Directors Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy DENVER, February 14, 2025 (BUSINESS WIRE) – Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solution |
|
| February 3, 2025 |
EX-99.2 2 ck0001669811-ex992.htm EX-99.2 EXHIBIT 99.2 The AI Catalyst Fund, LP Type Date Quantity Average Price Price Range: Minimum and Maximum Price Purchase 1/30/2025 45,000 4.35 4.28 4.42 Purchase 1/31/2025 187,500 4.03 3.85 4.13 Purchase 2/3/2025 187,500 3.87 3.66 3.96 The price reported in the “Average Price” column above excludes commissions and fees and reflects the weighted average purcha |
|
| February 3, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only |
|
| January 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by R |
|
| January 13, 2025 |
EXHIBIT 99.4 SCHEDULE OF TRANSACTIONS The following table sets forth all transactions in the shares of Common Stock effected by the Reporting Person in open market since the filing of Amendment No. 3 on December 18, 2024. Date Number of Shares Transaction Type Price Per Share in ($) (1) Fill Prices in ($) (2) 01/13/2025 262,532 Sale 6.53 6.33 to 6.87 01/10/2025 271,339 Sale 6.97 6.51 to 7.505 01/1 |
|
| January 10, 2025 |
Exhibit 99.3 The risks described below are being disclosed in order to update the risks described under the caption “Risk Factors” in Part I, Item 1A of the Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”) filed by the Company, as updated by the risks described under the caption “Risk Factors” in Part II, Item 1A of the Quarterly Report on Form 10-Q for the qua |
|
| January 10, 2025 |
Press release dated January 10, 2025. Exhibit 99.1 Modivcare Raises $105 Million in Incremental Financing Backed by Stakeholders Across the Capital Structure and Takes Strategic Steps to Position Business for the Future $75 Million in Incremental Term Loan and $30 Million in New Second Lien Notes to Support Operational Improvements, Strategic Priorities and Covenant Relief Will Pursue Strategic Review of Assets with Key Company Adviso |
|
| January 10, 2025 |
Purchase and Exchange Agreement. Exhibit 10.3 PURCHASE AND EXCHANGE AGREEMENT The undersigned beneficial owners of the Old Notes (as defined herein) (collectively, the “Holders” and each, a “Holder”), severally and not jointly, enter into this Purchase and Exchange Agreement (the “Agreement”) with ModivCare Inc., a Delaware corporation (the “Company”), on January 9, 2025, whereby each Holder, severally and not jointly, will, subj |
|
| January 10, 2025 |
Exhibit 10.3 PURCHASE AND EXCHANGE AGREEMENT The undersigned beneficial owners of the Old Notes (as defined herein) (collectively, the “Holders” and each, a “Holder”), severally and not jointly, enter into this Purchase and Exchange Agreement (the “Agreement”) with ModivCare Inc., a Delaware corporation (the “Company”), on January 9, 2025, whereby each Holder, severally and not jointly, will, subj |
|
| January 10, 2025 |
Exhibit 99.1 Modivcare Raises $105 Million in Incremental Financing Backed by Stakeholders Across the Capital Structure and Takes Strategic Steps to Position Business for the Future $75 Million in Incremental Term Loan and $30 Million in New Second Lien Notes to Support Operational Improvements, Strategic Priorities and Covenant Relief Will Pursue Strategic Review of Assets with Key Company Adviso |
|
| January 10, 2025 |
Exhibit 99.2 |
|
| January 10, 2025 |
Exhibit 99.3 The risks described below are being disclosed in order to update the risks described under the caption “Risk Factors” in Part I, Item 1A of the Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”) filed by the Company, as updated by the risks described under the caption “Risk Factors” in Part II, Item 1A of the Quarterly Report on Form 10-Q for the qua |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 9, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Com |
|
| January 10, 2025 |
Exhibit 10.1 AMENDMENT NO. 5 Dated as of January 9, 2025 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 5 (this “Amendment”) is made as of January 9, 2025, by and among ModivCare Inc., a corporation organized under the laws of the State of Delaware (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan ChaseBank, N.A., as administrative |
|
| January 10, 2025 |
Fifth Amendment to the Credit Agreement. Exhibit 10.1 AMENDMENT NO. 5 Dated as of January 9, 2025 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 5 (this “Amendment”) is made as of January 9, 2025, by and among ModivCare Inc., a corporation organized under the laws of the State of Delaware (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan ChaseBank, N.A., as administrative |
|
| January 10, 2025 |
Exhibit 99.2 |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 9, 2025 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Com |
|
| January 10, 2025 |
Exhibit 10.2 EXCHANGE AGREEMENT The undersigned beneficial owners of the Old Notes (as defined herein) (the foregoing, together with (x) each successor or assign of any of the foregoing which executes a joinder agreement to this Agreement pursuant to Section 2.11 or Section 6.3 and (y) any successor entity of the foregoing that signs a joinder agreement to this Agreement pursuant to Section 1.4(iv |
|
| January 10, 2025 |
Exhibit 10.2 EXCHANGE AGREEMENT The undersigned beneficial owners of the Old Notes (as defined herein) (the foregoing, together with (x) each successor or assign of any of the foregoing which executes a joinder agreement to this Agreement pursuant to Section 2.11 or Section 6.3 and (y) any successor entity of the foregoing that signs a joinder agreement to this Agreement pursuant to Section 1.4(iv |
|
| December 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 23, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| December 13, 2024 |
Joint Filing Agreement Pursuant to Rule 13d-1 EX-99.8 2 d853017dex998.htm EX-99.8 Exhibit 8 Joint Filing Agreement Pursuant to Rule 13d-1 This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the “Act”) by and among the parties listed below, each referenced to herein as a “Joint Filer.” The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d |
|
| December 13, 2024 |
SC 13D/A 1 d853017dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 23)* ModivCare Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise |
|
| December 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 13, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| December 13, 2024 |
301 Commerce Street, Suite 3200 Fort Worth, Texas 76102-4140 Tel (817) 332-9500 Fax (817) 332-7463 EX-99.1 2 ef20039912ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 301 Commerce Street, Suite 3200 Fort Worth, Texas 76102-4140 Tel (817) 332-9500 Fax (817) 332-7463 December 13, 2024 Dear Members of the ModivCare Board: Currently, affiliates of Q Investments, L.P. directly hold approximately 14% of the Company’s common shares outstanding, approximately 5% of the Company’s Term Loan Facility, and approximat |
|
| December 13, 2024 |
MODV / ModivCare Inc. / Q Global Capital Management, L.p. - SC 13D/A Activist Investment SC 13D/A 1 ef20039912sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) MODIVCARE INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 60783X104 (CUSIP Number) Nelson Holm 301 Commerce Street, Suite 3200 Fort Worth, Texas 76102 (817) 332-9500 (Name, Addre |
|
| December 9, 2024 |
MODV / ModivCare Inc. / Q Global Capital Management, L.p. - SC 13D/A Activist Investment SC 13D/A 1 ef20039745sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) MODIVCARE INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 60783X104 (CUSIP Number) Nelson Holm 301 Commerce Street, Suite 3200 Fort Worth, Texas 76102 (817) 332-9500 (Name, Addre |
|
| November 14, 2024 |
MODV / ModivCare Inc. / HG Vora Capital Management, LLC Passive Investment SC 13G 1 mci1112244sc13g.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment ) Under the Securities Exchange Act of 1934 ModivCare Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60783X104 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| November 8, 2024 |
MODV / ModivCare Inc. / Q Global Capital Management, L.p. - SC 13D Activist Investment SC 13D 1 ef20038317sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 MODIVCARE INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 60783X104 (CUSIP Number) Nelson Holm 301 Commerce Street, Suite 3200 Fort Worth, Texas 76102 (817) 332-9500 (Name, Address and Telephone Number |
|
| November 7, 2024 |
EXECUTION COPY AMENDMENT NO. 4 Dated as of September 30, 2024 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 4 (this “Amendment”) is made as of September 30, 2024 by and among ModivCare Inc., a corporation organized under the laws of the State of Delaware (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as adminis |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivC |
|
| November 6, 2024 |
Modivcare Reports Third Quarter 2024 Financial Results; Affirms 2024 Guidance Modivcare Reports Third Quarter 2024 Financial Results; Affirms 2024 Guidance Denver, CO – November 6, 2024 – Modivcare Inc. |
|
| November 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| October 28, 2024 |
MODV / ModivCare Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment SC 13G/A 1 MODVSC13GA2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 2) MODIVCARE INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 60783X104 (CUSIP Number) SEPTEMBER 30, 2024 (Date of event which requires filing of this statement) Check the appropriate bo |
|
| October 25, 2024 |
MODV / ModivCare Inc. / Q Global Capital Management, L.p. Passive Investment SC 13G/A 1 sc13gano1modv.htm SC 13G 1 ef20031867sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* MODIVCARE INC (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 60783X104 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of th |
|
| October 25, 2024 |
MODV / ModivCare Inc. / Q Global Capital Management, L.p. Passive Investment SC 13G/A 1 sc13gano2modv.htm SC 13G 1 ef20031867sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* MODIVCARE INC (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 60783X104 (CUSIP Number) October 23, 2024 (Date of Event which Requires Filing of this |
|
| October 1, 2024 |
Fourth Amendment to the Credit Agreement. CREDIT AGREEMENT dated as of February 3, 2022 among MODIVCARE INC. The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent TRUIST BANK and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Co-Syndication Agents TRUIST BANK, WELLS FARGO BANK, NATIONAL ASSOCIATION, DEUTSCHE BANK SECURITIES INC., REGIONS BANK and CAPITAL ONE, NATIONAL ASSOCIATION, as Co-Syndication Agents in connection wi |
|
| October 1, 2024 |
Modivcare Announces Credit Agreement Amendment and Cash Collections Update Modivcare Announces Credit Agreement Amendment and Cash Collections Update Denver, CO – October 1, 2024 – ModivCare Inc. |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2024 (September 30, 2024) ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation |
|
| September 19, 2024 |
ModivCare Inc. 6900 E. Layton Avenue, 12th Floor Denver, Colorado 80237 (303) 728-7012 September 19, 2024 VIA EDGAR Anuja Majmudar Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: ModivCare Inc. Registration Statement on Form S-3 Filed September 12, 2024 File No. 333-282051 Dear Ms. Majmudar: Pursuant to the provisions of Rule 461 und |
|
| September 16, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation) (Commission File |
|
| September 16, 2024 |
Modivcare Provides Financial Update Exhibit 99.1 Modivcare Provides Financial Update September 16, 2024 Denver, CO – Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today addressed its recent filings with the U.S. Securities and Exchange Commission (“SEC”) and announced adj |
|
| September 12, 2024 |
Filing Fee Table (filed herewith). Calculation of Filing Fee Tables S-3 ModivCare Inc Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Equity Common Stock, par value $0. |
|
| September 12, 2024 |
PART II Item 8. Financial Statements and Supplementary Data. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Reports of Independent Registered Public Accounting Firm (KPMG LLP, Denver, CO, Auditor Firm ID: 185) 2 Report of Independent Registered Public Accounting Firm (Deloitte & Touche LLP, Tempe, AZ, Auditor Firm ID: 34) 3 Reports of Independent Registered Public Accounting Firm (KPMG LLP, Denver, CO |
|
| September 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 12, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) ( |
|
| September 12, 2024 |
As filed with the Securities and Exchange Commission on September 12, 2024 As filed with the Securities and Exchange Commission on September 12, 2024 Registration No. |
|
| September 12, 2024 |
Form of Indenture (filed herewith). Exhibit 4.1 MODIVCARE INC. INDENTURE Dated as of , 20 Providing for Issuance of Senior Debt Securities in Series as Trustee TABLE OF CONTENTS Page Article 1. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 6 Section 1.03. Incorporation by Reference of Trust Indenture Act 7 Section 1.04. Rules of Construction 7 Section 1.05. Acts of Holders 8 |
|
| August 8, 2024 |
6900 E Layton Ave Office 303.931.0224 Suite 1200 Denver, CO 80237 modivcare.com May 6, 2024 VIA Email: [email protected] Re: Amendment to Your March 15, 2023 Offer of Employment Dear Anne: During the 2024 Proxy season Modivcare identified an oversight contained in your March 15, 2023 offer of employment. Specifically, page 3, paragraph 1, provides six (6) months severance in the event your |
|
| August 8, 2024 |
, 2024, by and between the Registrant and SEPARATION AGREEMENT AND GENERAL RELEASE between Anne Bailey care Solutions, LLC, on its behalf and wholly owned subsidiaries, affiliates, and its parent organization ends effective June 21, 2024 . |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare I |
|
| August 8, 2024 |
, by and between the Registrant and Ilias Simpson. SEPARATION AGREEMENT AND GENERAL RELEASE Ilias Simpson c terminate effective May 2, 2024 . |
|
| August 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Comm |
|
| August 7, 2024 |
Modivcare Reports Second Quarter 2024 Financial Results; Adjusts 2024 Guidance Modivcare Reports Second Quarter 2024 Financial Results; Adjusts 2024 Guidance Denver, CO – August 7, 2024 – Modivcare Inc. |
|
| July 3, 2024 |
Modivcare Announces Successful Refinancing Modivcare Announces Successful Refinancing Denver, CO – July 3, 2024 – Modivcare Inc. |
|
| July 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 1, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commis |
|
| July 3, 2024 |
EXECUTION COPY AMENDMENT NO. 3 Dated as of July 1, 2024 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 3 (this “Amendment”) is made as of July 1, 2024 by and among ModivCare Inc., a corporation organized under the laws of the State of Delaware (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as administrative agen |
|
| June 28, 2024 |
MODV / ModivCare Inc. / Q Global Capital Management, L.p. - SC 13G Passive Investment SC 13G 1 ef20031867sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MODIVCARE INC (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 60783X104 (CUSIP Number) June 20, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate |
|
| June 12, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 11, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| May 23, 2024 |
MODV / ModivCare Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment SC 13G/A 1 MODVSC13GA1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) MODIVCARE INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 60783X104 (CUSIP Number) MAY 14, 2024 (Date of event which requires filing of this statement) Check the appropriate box to d |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 16, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commis |
|
| May 15, 2024 |
Investor Presentation, dated May 15, 2024. Exhibit 99.1 |
|
| May 15, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2024 ModivCare Inc. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| May 9, 2024 |
MODV / ModivCare Inc. / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-05092024050521.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* ModivCare Inc (Name of Issuer) Common (Title of Class of Securities) 60783X104 (CUSIP Number) April 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| May 3, 2024 |
Form of 2024 Performance Restricted Stock-Unit Agreement PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT To: %%FIRSTNAME MIDDLENAMELASTNAME%-% You are hereby awarded, effective as of the Date of Grant, performance restricted stock units (each a “PRSU” and collectively the “PRSUs”) representing the right to receive shares of common stock, $. |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare |
|
| May 2, 2024 |
Modivcare Reports First Quarter 2024 Financial Results; Maintains Guidance Modivcare Reports First Quarter 2024 Financial Results; Maintains Guidance Denver, CO – May 2, 2024 – Modivcare Inc. |
|
| May 2, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 2, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 12, 2024 |
MODV / ModivCare Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 MODIVCARE INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 60783X104 (CUSIP Number) APRIL 3, 2024 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 1, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| February 26, 2024 | ||
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. |
|
| February 26, 2024 |
, 2023, by and between the registrant and Anne Bailey. 1 March 15, 2023 Anne Bailey 3153 Tamarac Street Denver, CO 80238 Dear Anne Bailey, It gives me great pleasure to offer you the President - Home position with Modivcare. |
|
| February 26, 2024 |
Subsidiaries of the Registrant. Exhibit 21.1 Name of Subsidiary State/Country of Incorporation Unless otherwise noted all subsidiaries listed are, directly or indirectly, wholly owned by ModivCare Inc. ModivCare Solutions, LLC Delaware Circulation, Inc. Delaware Health Trans, Inc. Delaware Provado Technologies, LLC Florida Red Top Transportation, Inc. Florida Ride Plus, LLC Delaware Ingeus Investments Limited United Kingdom Inge |
|
| February 26, 2024 |
Description of the registrant's securities registered pursuant to Section 12 of the Exchange Act. Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 DESCRIPTION OF CAPITAL STOCK The following summary of the terms of ModivCare Inc. (the “Company”) capital stock is based upon the Company’s Second Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), and the Company’s Amended |
|
| February 26, 2024 |
Clawback Policy, as effective November 2, 2023. DODD-FRANK CLAWBACK POLICY MEMO TO: Holding Company and Subsidiary Employees Subject to Dodd-Frank Clawback Policy FROM: L. |
|
| February 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 22, 2024 |
Modivcare Reports Fourth Quarter and Full Year 2023 Financial Results; Issues 2024 Guidance Modivcare Reports Fourth Quarter and Full Year 2023 Financial Results; Issues 2024 Guidance Denver, CO – February 22, 2024 – Modivcare Inc. |
|
| February 22, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 22, 2024 |
Execution Version AMENDMENT NO. 2 Dated as of February 22, 2024 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 2 (this “Amendment”) is made as of February 22, 2024 by and among, Modivcare, Inc., a corporation organized under the laws of the State of Delaware (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as admi |
|
| February 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2024 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 14, 2024 |
EX-99.1 2 d706562dex991.htm EX-99.1 Exhibit 1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of February 14, 2024, is by and among Silvercrest Asset Management Group LLC, Silvercrest L.P. and Silvercrest Asset Management Group Inc. (collectively, the “Filers”). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule |
|
| February 14, 2024 |
MODV / ModivCare Inc. / SILVERCREST ASSET MANAGEMENT GROUP LLC - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ModivCare Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 60783X104 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| February 13, 2024 |
MODV / ModivCare Inc. / Neuberger Berman Group LLC Passive Investment SC 13G 1 formsc13g-02132024080217.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ModivCare Inc (Name of Issuer) Common (Title of Class of Securities) 60783X104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| February 13, 2024 |
MODV / ModivCare Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01473-modivcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: ModivCare Inc Title of Class of Securities: Common Stock CUSIP Number: 60783X104 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rul |
|
| November 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivC |
|
| November 3, 2023 |
July 31, 2023 Barbara K. Gutierrez Littleton, CO Dear Barbara, It gives me great pleasure to offer you the Chief Financial Officer position with Modivcare. In addition to confirming our offer, this letter will detail the terms and conditions of your employment and outline the current major features of Modivcare's compensation and benefit plans and practices. All offers of employment are contingent |
|
| November 2, 2023 |
Modivcare Reports Third Quarter 2023 Financial Results; Maintains Guidance Modivcare Reports Third Quarter 2023 Financial Results; Maintains Guidance Denver, CO – November 2, 2023 – Modivcare Inc. |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| October 27, 2023 |
Modivcare Announces Resignation of Stacy Saal from Board of Directors Exhibit 99.1 Modivcare Announces Resignation of Stacy Saal from Board of Directors DENVER – October 27, 2023 – Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Stacy Saal has stepped down from the Board of Director |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 23, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| September 18, 2023 |
SC 13D/A 1 d506096dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 22)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephon |
|
| September 13, 2023 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 21)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephone Number of Person Authorized |
|
| September 11, 2023 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 20)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephone Number of Person Authorized |
|
| August 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 23, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Com |
|
| August 23, 2023 |
Modivcare Announces Barbara Gutierrez to Join as Chief Financial Officer Exhibit 99.1 Modivcare Announces Barbara Gutierrez to Join as Chief Financial Officer DENVER – August 23, 2023 – Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Barbara Gutierrez has agreed to join Modivcare as it |
|
| August 11, 2023 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 19)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephone Number of Person Authorized |
|
| August 10, 2023 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 18)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephone Number of Person Authorized |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare I |
|
| August 3, 2023 |
Modivcare Reports Second Quarter 2023 Financial Results and Adjusts 2023 Guidance Modivcare Reports Second Quarter 2023 Financial Results and Adjusts 2023 Guidance Denver, CO – August 3, 2023 – Modivcare Inc. |
|
| August 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Comm |
|
| June 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 ModivCare Inc. |
|
| June 26, 2023 |
Exhibit 10.1 Execution Version AMENDMENT NO. 1 Dated as of June 26, 2023 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 1 (this “Amendment”) is made as of June 26, 2023 by and among, Modivcare, Inc., a corporation organized under the laws of the State of Delaware (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as |
|
| June 15, 2023 |
Exhibit 3.2 AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF MODIVCARE INC. This Amendment (“Amendment”) to the Amended and Restated Bylaws (the “Bylaws”) of ModivCare Inc., a Delaware corporation (the “Corporation”), amends the Bylaws as follows: 1. Amendment to Section 1.03. The first sentence of clause (a) of Section 1.03 of Article I of the Bylaws is hereby amended and restated in its entirety |
|
| June 15, 2023 |
Exhibit 3.1 THIRD AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MODIVCARE INC. The undersigned, desiring to amend the certificate of incorporation of a Delaware corporation pursuant to Section 242 of the Delaware General Corporation Law (the “Act”), hereby certifies as follows: FIRST. The name of the corporation (hereinafter called the “Corporation”) is ModivCare Inc |
|
| June 15, 2023 |
-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 13, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 18, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commis |
|
| May 18, 2023 |
SETTLEMENT AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS Exhibit 99.1 SETTLEMENT AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS This Settlement Agreement and General Release of All Claims (“Agreement”) is between Daniel Greenleaf (“Greenleaf”) and Modivcare Inc. and Modivcare Solutions, LLC (collectively, “Modivcare”). WHEREAS on November 29, 2019, Greenleaf and Modivcare’s predecessors “The Providence Service Corporation” and “Logisticare Solutions, LLC” |
|
| May 18, 2023 |
Modivcare Resolves Dispute With Former Chief Executive Officer Exhibit 99.2 Modivcare Resolves Dispute With Former Chief Executive Officer DENVER – May 18, 2023 – Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company and its former Chief Executive Officer, Daniel E. Gre |
|
| May 10, 2023 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 17)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephone Number of Person Authorized |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare |
|
| May 4, 2023 |
Exhibit 10.1 PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT To: [RECIPIENT] Date of Grant: [DATE] You are hereby awarded, effective as of the Date of Grant, [●] performance restricted stock units (each a “PRSU” and collectively the “PRSUs”) representing the right to receive shares of common stock, $.001 par value (“Common Stock”), of ModivCare Inc., a Delaware corporation (the “Company”), pursuant to |
|
| May 4, 2023 |
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE This Confidential Separation Agreement and General Release (the “Agreement”) is entered into between Grover Wray (“Employee”) and Modivcare Solutions, LLC (the “Company”), collectively referred to as the “Parties. |
|
| May 4, 2023 |
Modivcare Reports First Quarter 2023 Financial Results Modivcare Reports First Quarter 2023 Financial Results Denver, CO – May 4, 2023 – Modivcare Inc. |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| March 7, 2023 |
TRANSITION AGREEMENT This Transition Agreement (“Transition Agreement”) is entered into on December 15, 2022, between Walt Meffert (“Employee”) and Modivcare Solutions, LLC (the “Company”), collectively referred to as the “Parties. |
|
| March 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. |
|
| March 7, 2023 |
Exhibit 10.11 MODIVCARE INC. DIRECTOR COMPENSATION SUMMARY As compensation for their service as directors of ModivCare Inc. (the “Company”), each non-employee member of the Board of Directors (the “Board”) receives an annual retainer composed of a combination of cash and Company equity. All retainers are prorated for partial periods of service. Each non-employee member of the Board receives an ann |
|
| March 7, 2023 |
Subsidiaries of the Registrant. Exhibit 21.1 Name of Subsidiary State/Country of Incorporation Unless otherwise noted all subsidiaries listed are, directly or indirectly, wholly owned by ModivCare Inc. ModivCare Solutions, LLC Delaware Circulation, Inc. Delaware Health Trans, Inc. Delaware Provado Technologies, LLC Florida Red Top Transportation, Inc. Florida Ride Plus, LLC Delaware Ingeus Investments Limited United Kingdom Inge |
|
| March 7, 2023 |
ex1021defcompplan [Sample Deferral Plan 2008-12-01.docx] BST99 1605181-5.083572.0011 SPECIMEN FORM: There are many possible forms that could be used to implement a nonqualified deferred compensation plan that is subject to Section 409A. The advisability of using this form and the tax implications resulting from its adoption in its existing form should be determined by each company's attorney and o |
|
| March 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 001-34221 FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER 60783X104 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra |
|
| February 23, 2023 |
Modivcare Reports Fourth Quarter and Full Year 2022 Financial Results; Issues 2023 Guidance Modivcare Reports Fourth Quarter and Full Year 2022 Financial Results; Issues 2023 Guidance Denver, CO – February 23, 2023 – Modivcare Inc. |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 15, 2023 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| February 9, 2023 |
MODV / ModivCare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: ModivCare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60783X104 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule |
|
| November 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 21, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivC |
|
| November 8, 2022 |
August 22, 2022 Rebecca Orcutt 435 S Gaylord Street Denver, CO 80209 Dear Rebecca, Based on your performance to date and commitment to Modivcare, we are pleased to offer you the position of Sr. |
|
| November 3, 2022 |
Modivcare Reports Third Quarter 2022 Financial Results and Updates 2022 Guidance EX-99.1 2 a-ex991xmodvq32022pressrel.htm EX-99.1 Modivcare Reports Third Quarter 2022 Financial Results and Updates 2022 Guidance Denver, CO – November 3, 2022 – Modivcare Inc., (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving patient outcomes, today reported financi |
|
| November 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 3, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| November 1, 2022 |
L. Heath Sampson Confirmed as Modivcare’s President and Chief Executive Officer Exhibit 99.1 L. Heath Sampson Confirmed as Modivcare?s President and Chief Executive Officer DENVER ? November 1, 2022 ? Modivcare Inc. (the ?Company? or ?Modivcare?) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Board of Directors has confirmed the app |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| August 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Com |
|
| August 8, 2022 |
Exhibit 10.3 March 25, 2022 Ilias Simpson Mason, OH Dear Ilias, It gives me great pleasure to offer you the position of President, Transportation with Modivcare. In addition to confirming our offer, this letter will detail the terms and conditions of your employment and outline the current major features of Modivcare's compensation and benefit plans and practices. All offers of employment are cont |
|
| August 8, 2022 |
Exhibit 10.2 March 22, 2022 Brett Hickman 4402 W. Woodbridge Ln New Palestine, IN 46163 Dear Brett, It gives me great pleasure to offer you the position of Chief Commercial Officer with Modivcare. In addition to confirming our offer, this letter will detail the terms and conditions of your employment and outline the current major features of Modivcare's compensation and benefit plans and practices |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare I |
|
| August 4, 2022 |
Modivcare Reports Second Quarter 2022 Financial Results and Updates 2022 Guidance Modivcare Reports Second Quarter 2022 Financial Results and Updates 2022 Guidance Denver, CO ? August 4, 2022 ? Modivcare Inc. |
|
| August 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Comm |
|
| August 2, 2022 |
Exhibit 99.1 Modivcare Announces Leadership Transition Chief Financial Officer L. Heath Sampson Appointed Interim Chief Executive Officer Board Initiates Search for Permanent Successor DENVER, August 2, 2022 – Modivcare Inc., (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on im |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 27, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| June 23, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 23, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| June 23, 2022 |
--financial tables to follow-- Exhibit 99.1 Supplemental Historical Segment Financial Information of Modivcare Inc. Effective January 1, 2022, the Company completed a segment reorganization that resulted in the establishment of a Corporate and Other segment, which includes the costs associated with our activities related to executive, accounting, finance, internal audit, tax, legal and strategic and corporate development functi |
|
| June 22, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) ModivCare Inc. (Exact name of Registrant as Specified in its Charter) Table 1 ? Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity |
|
| June 22, 2022 |
As filed with the U.S. Securities and Exchange Commission on June 21, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State of Incorporation or organization) (I.R.S. Employer Identification No. |
|
| June 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 15, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| June 14, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commi |
|
| May 5, 2022 |
May 2022 Investor Presentation Copyright ? 2022 ModivCare? Inc. Forward Looking Statements Copyright ? 2022 ModivCare? Inc. 2 Certain statements contained in this presentation constitute ?forward-looking statements? within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as ?may,? ? |
|
| May 5, 2022 |
Modivcare Reports First Quarter 2022 Financial Results Modivcare Reports First Quarter 2022 Financial Results Denver, CO ? May 5, 2022 ? Modivcare Inc. |
|
| May 5, 2022 |
EXHIBIT 10.1 PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT To: [RECIPIENT] Date of Grant: [DATE] You are hereby awarded, effective as of the Date of Grant, [?] performance restricted stock units (each a ?PRSU? and collectively the ?PRSUs?) representing the right to receive shares of common stock, $.001 par value (?Common Stock?), of ModivCare Inc., a Delaware corporation (the ?Company?), pursuant to |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| May 2, 2022 |
DEFA14A 1 edge20002809x2defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Prelimi |
|
| May 2, 2022 |
DEF 14A 1 edge20002809x1def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropria |
|
| March 1, 2022 |
, 2021, by and among the registrant, ModivCare Solutions, LLC and Jonathan B. Bush. July 22, 2021 Jonathan Bush 10417 Maplebrook Way Hghlnds Ranch, Colorado 80126-5768 Dear Jonathan, It gives me great pleasure to offer you a position with ModivCare. |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. |
|
| March 1, 2022 |
Subsidiaries of the Registrant. Exhibit 21.1 Name of Subsidiary State/Country of Incorporation Unless otherwise noted all subsidiaries listed are, directly or indirectly, wholly owned by ModivCare Inc. ModivCare Solutions, LLC Delaware Circulation, Inc. Delaware Health Trans, Inc. Delaware Provado Technologies, LLC Florida Red Top Transportation, Inc. Florida Ride Plus, LLC Delaware Ingeus Investments Limited United Kingdom Inge |
|
| March 1, 2022 |
January 27, 2020 Walt Meffert 610 E Market St. Unit 3116 San Antonio, TX 78205 [email protected] 410-916-8400 Dear Walt, It gives me great pleasure to offer you a position with LogistiCare. In addition to confirming our offer, this letter will detail the terms and conditions of your employment and outline the current major features of LogistiCare's compensation and benefit plans and practices. All o |
|
| March 1, 2022 |
Financial Statements of Mercury Parent, LLC. Mercury Parent, LLC Consolidated Financial Statements as of December 31, 2021 and 2020, and for the Years Ended December 31, 2021, 2020, and 2019, and Report of Independent Registered Public Accounting Firm MERCURY PARENT, LLC TABLE OF CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1-2 CONSOLIDATED FINANCIAL STATEMENTS: Consolidated Balance Sheets as of December 31, 2021 and |
|
| March 1, 2022 |
, 2021, by and among the registrant, ModivCare Solutions, LLC and Kenneth Shepard. July 22, 2021 Kenneth Shepard 1325 Dover Cir Ne Brookhaven, Georgia 30319 Dear Kenneth, It gives me great pleasure to offer you a position with ModivCare. |
|
| March 1, 2022 |
Exhibit 10.9 MODIVCARE INC. DIRECTOR COMPENSATION SUMMARY As compensation for their service as directors of ModivCare Inc. (the ?Company?), each non-employee member of the Board of Directors (the ?Board?) receives an annual retainer composed of a combination of cash and Company equity. All retainers are prorated for partial periods of service. Each non-employee member of the Board receives an annu |
|
| March 1, 2022 |
, 2021, by and among the registrant, ModivCare Solutions, LLC and October 14, 2021 Grover Wray 13937 Pinehurst Circle Broomfield, CO, 80023 Dear Grover, It gives me great pleasure to offer you a position with Modivcare. |
|
| March 1, 2022 | ||
| February 25, 2022 |
February 2022 Investor Presentation Forward Looking Statements 2 Certain statements contained in this presentation constitute ?forward-looking statements? within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| February 25, 2022 |
Modivcare Reports Fourth Quarter and Full Year 2021 Financial Results Modivcare Reports Fourth Quarter and Full Year 2021 Financial Results Denver, CO ? February 25, 2022 ? Modivcare Inc. |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (C |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 8, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| February 10, 2022 |
MODV / ModivCare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: ModivCare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60783X104 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2022 ModivCare Inc. |
|
| February 4, 2022 |
Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT dated as of February 3, 2022 among MODIVCARE INC. The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent TRUIST BANK and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Co-Syndication Agents DEUTSCHE BANK AG NEW YORK BRANCH, BANK OF AMERICA, N.A., REGIONS BANK, BANK OF MONTREAL and CAPITAL ONE, NATIONAL ASSOCIATION, as Co-Documentation |
|
| January 10, 2022 |
Exhibit 99.1 Modivcare Aligns In-Home Services into a New Division ? Modivcare Home - Promotes Jason E. Anderson to Leader of Modivcare Home - DENVER ? January 10, 2021 ? Modivcare Inc. (?Modivcare? or the ?Company?) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today announced t |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 4, 2022 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Com |
|
| November 5, 2021 |
ModivCare Reports Third Quarter 2021 Financial Results ModivCare Reports Third Quarter 2021 Financial Results Denver, CO ? November 5, 2021 ? ModivCare Inc. |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivC |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 5, 2021 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Co |
|
| November 5, 2021 |
EX-99.2 3 modivcareinvestorpresent.htm EX-99.2 November 2021 Investor Presentation Certain statements contained in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “esti |
|
| September 22, 2021 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2021 ModivCare Inc. |
|
| September 22, 2021 |
ModivCare Completes Acquisition of VRI Exhibit 99.1 ModivCare Completes Acquisition of VRI DENVER ? September 22, 2021 ? ModivCare Inc. (?ModivCare? or the ?Company?) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today announced that the Company has completed its previously announced acquisition of VRI Intermediate Ho |
|
| September 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2021 ModivCare Inc. |
|
| September 14, 2021 |
ModivCare Completes Acquisition of CareFinders EX-99.1 3 ex283785.htm EXHIBIT 99.1 Exhibit 99.1 ModivCare Completes Acquisition of CareFinders DENVER – September 14, 2021 – ModivCare Inc. (“ModivCare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today announced that the Company has completed its previously |
|
| September 14, 2021 |
Exhibit 10.1 NINTH AMENDMENT TO CREDIT AGREEMENT THIS NINTH AMENDMENT TO CREDIT AGREEMENT dated as of September 13, 2021 (the ?Agreement?) is entered into among ModivCare Inc. (formerly known as The Providence Service Corporation), a Delaware corporation (the ?Borrower?), the Guarantors, the Lenders party hereto and Bank of America, N.A., as Administrative Agent. All capitalized terms used herein |
|
| September 9, 2021 |
Providence Service Corp. (The) / Coliseum Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 16)* ModivCare Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 743815102 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Ave. Rowayton, CT 06853 (Name, Address and Telephone Number of Person Authorized |
|
| August 24, 2021 |
Exhibit 4.1 EXECUTION VERSION SENIOR NOTES INDENTURE Dated as of August 24, 2021 Between MODIVCARE ESCROW ISSUER, INC., as the Escrow Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee 5.000% SENIOR NOTES DUE 2029 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 24 Section 1.03 Rules of Const |
|
| August 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 24, 2021 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 11, 2021 |
ModivCare Announces Pricing of its $500 Million Private Offering of Senior Notes EX-99.1 2 ex274905.htm EXHIBIT 99.1 Exhibit 99.1 ModivCare Announces Pricing of its $500 Million Private Offering of Senior Notes ATLANTA, GA – August 11, 2021 – ModivCare Inc. (“ModivCare”) (Nasdaq: MODV), today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $500 million in aggregate principal amount of senior notes due on October 1, |
|
| August 11, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 11, 2021 (August 11, 2021) ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or |
|
| August 9, 2021 |
Investor Presentation, dated August 9, 2021. EX-99.1 3 ex273367.htm EXHIBIT 99.1 Exhibit 99.1 |
|
| August 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2021 (August 6, 2021) ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or or |
|
| August 9, 2021 |
Exhibit 10.1 CONSENT AGREEMENT THIS CONSENT AGREEMENT dated as of August 6, 2021 (this ?Agreement?) is entered into among ModivCare Inc. (formerly known as The Providence Service Corporation), a Delaware corporation (the ?Borrower?), the Guarantors, the Lenders party hereto and Bank of America, N.A., as Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall |
|
| August 9, 2021 |
ModivCare Announces $400 Million Private Offering of Senior Notes EX-99.2 4 ex273247.htm EXHIBIT 99.2 Exhibit 99.2 ModivCare Announces $400 Million Private Offering of Senior Notes ATLANTA, GA – August 9, 2021 – ModivCare Inc. (“ModivCare”) (Nasdaq: MODV), today announced a private placement offering of $400 million in aggregate principal amount of newly issued senior notes maturing in 2029 (the “notes”), issued by ModivCare Escrow Issuer, Inc. (the “Escrow Issu |
|
| August 6, 2021 |
ModivCare Reports Second Quarter 2021 Financial Results ModivCare Reports Second Quarter 2021 Financial Results Denver, CO – August 6, 2021 – ModivCare Inc. |
|
| August 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2021 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 001-34221 86-0845127 (State or other jurisdiction of incorporation or organization) (Comm |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare I |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2021 ModivCare Inc. |
|
| August 3, 2021 |
Exhibit 10.1 DEUTSCHE BANK AG NEW YORK BRANCH DEUTSCHE BANK AG CAYMAN ISLAND BRANCH DEUTSCHE BANK SECURITIES INC. 60 Wall Street New York, New York 10005 JEFFERIES FINANCE LLC 520 Madison Avenue New York, New York 10022 CONFIDENTIAL August 2, 2021 COMMITMENT LETTER ModivCare Inc. 6900 Layton Avenue, 12th Floor Denver, Colorado 80237 Attention: L. Heath Sampson, Chief Financial Officer Jon Bush, Se |
|
| August 3, 2021 |
Investor Presentation dated August 3, 2021. EX-99.2 5 ex270947.htm EXHIBIT 99.2 Exhibit 99.2 |
|
| August 3, 2021 |
Exhibit 99.1 ModivCare Announces Acquisition of VRI, a Leading Provider of Remote Patient Monitoring Solutions in the United States - Adds a critical supportive care platform with unique data analytics to benefit payors and patients - - Attractive financial profile with mid-teens recurring revenue growth and strong margins - DENVER – August 3, 2021 – ModivCare Inc. (“ModivCare” or the “Company”) ( |
